
Bupraset 150mg Tablet XR
Marketer
La Renon Healthcare Pvt Ltd
Salt Composition
Bupropion (150mg)
Overview Bupraset 150mg Tablet XR
Extended-release Bupraset 150mg tablets treat depression and nicotine dependence by boosting brain neurotransmitters, promoting relaxation and calmness. Bupraset 150mg XR can be taken with or without food, consistently at the same time daily. Complete the prescribed course, even if symptoms improve; abruptly stopping treatment may exacerbate symptoms. Potential side effects include sleep disturbances, allergic responses, concentration difficulties, perspiration, headaches, nausea, vomiting, dry mouth, dizziness, and drowsiness. Avoid activities requiring alertness while using this medication. Most side effects are transient. Report persistent or bothersome side effects to your physician. Prior to commencing treatment, disclose any history of seizures or alcohol use. Immediately report any unusual mood shifts or suicidal ideation to your doctor.
Uses of Bupraset 150mg Tablet XR
Tobacco dependence and depressive disorder
Major Benefits of Bupraset 150mg Tablet XR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Bupraset 150mg Extended-Release Tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent daily timing is recommended.
Common Side effects of Bupraset 150mg Tablet XR:
- Insomnia (difficulty in sleeping)
- Allergic reaction
- Impaired concentration
- Sweating
- Headache
- Nausea
- Vomiting
- Dizziness
- Dryness in mouth
- Taste change
- Abdominal pain
- Agitation
- Anxiety
- Fever
- Constipation
- Tremors
How to use Bupraset 150mg Tablet XR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bupraset 150mg Extended-Release Tablets can be consumed with or without food, although consistent timing is recommended.
How Bupraset 150mg Tablet XR works:
Extended-release Bupraset 150mg tablets treat depression by elevating neurotransmitter concentrations in the brain, thereby improving mood regulation. The precise mechanism by which it aids in smoking cessation remains unclear.
SAFETY ADVICE
AlcoholUNSAFE
Extended-release Bupraset 150mg tablets can induce increased sleepiness when combined with alcohol.
PregnancyCONSULT YOUR DOCTOR
Extended-release Bupraset 150mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against these risks prior to prescription. Seek medical advice.
Breast feedingCAUTION
Extended-release Bupraset 150mg tablets necessitate careful consideration during lactation. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
Extended-release Bupraset 150mg tablets can induce adverse reactions that impair driving capabilities. These reactions may include dizziness, lightheadedness, reduced concentration, and impaired judgment, all potentially affecting the ability to drive safely.
KidneyCAUTION
Extended-release Bupraset 150mg tablets require careful administration for individuals with impaired renal function. Dosage modification of Bupraset 150mg extended-release tablets may be necessary. Physician consultation is recommended.
LiverCAUTION
Extended-release Bupraset 150mg tablets require careful consideration for individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is recommended. Close medical supervision is advised for patients using this medication to monitor for potential adverse reactions.
What if you forget to take Bupraset 150mg Tablet XR :
Omit any missed Bupraset 150mg Tablet XR dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Bupraset 150mg Tablet XR
| Label | Value |
|---|---|
| Chemical Category | Propiophenone Derivative |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Behavior Class | Norepinephrine and dopamine reuptake inhibitor |
